newly diagnosed acute myeloid leukemia
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)
Recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 13, 2022
UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic
Recruiting
- UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
- Basic chemotherapy + UCB transplantation
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Oct 9, 2022
Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte
Recruiting
- Acute Myeloid Leukemia
- Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
- "3+7"
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Sep 29, 2023
Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)
Recruiting
- Newly Diagnosed Acute Myeloid Leukemia (AML)
- SKLB1028 Dose Escalation
-
Chengdu, ChinaWest China Hospital of Sichuan University
Jun 30, 2022
Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine Combined With Venetoclax and ATRA group
-
Suzhou, Chinathe First Affiliated Hospital of Soochow University
Dec 8, 2022
Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen
Not yet recruiting
- Leukemia, Myeloid, Acute
- AML Stage, Adult
- Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
-
Xiamen, Fujian, ChinaBing Xu
Oct 29, 2022
Venetoclax Plasma Concentration and Remission in Acute Myeloid
Not yet recruiting
- Adult Acute Myeloid Leukemia
- Blood sampling for venetoclax drug dosage (venous puncture)
- (no location specified)
Sep 13, 2023
Acute Myeloid Leukemia (AML) Trial in Tianjin (Quizartinib)
Completed
- Acute Myeloid Leukemia (AML)
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
Jul 27, 2022
Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +5 more
-
Chicago, IllinoisNorthwestern University
Feb 16, 2023
Single-cell Dynamic Profiling in Newly Diagnosed Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- Biobanking blood and bone marrow specimens
- (no location specified)
Mar 21, 2022
Acute Myeloid Leukemia Trial in Tampa (Vyxeos, Gemtuzumab Ozogamicin)
Recruiting
- Acute Myeloid Leukemia
- Vyxeos
- Gemtuzumab Ozogamicin
-
Tampa, FloridaMoffitt Cancer Center
Sep 23, 2022
Acute Myeloid Leukemia, MDS Trial in Ulm (drug, combination product, other)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Venetoclax
- +4 more
-
Berlin, Germany
- +9 more
Jan 13, 2023
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Recruiting
- Acute Bilineal Leukemia
- +8 more
- Azacitidine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 24, 2023
Acute Myeloid Leukemia Trial in Baltimore, New York, Chapel Hill (Alvocidib, Cytarabine, Daunorubicin)
Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel
Recruiting
- Acute Myeloid Leukemia
- +5 more
- Biospecimen Collection
- +3 more
-
Baltimore, Maryland
- +2 more
Jan 19, 2023
AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)
Recruiting
- AML
- Acute Myeloid Leukemia
-
Charlottesville, VirginiaUniversity of Virginia
Jul 2, 2022
Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Venetoclax Oral Tablet
- +2 more
-
Bronx, New YorkMontefiore Einstein Cancer Center
Jul 14, 2022
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +13 more
- Sirolimus
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 2, 2023
Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)
Not yet recruiting
- Acute Myeloid Leukemia
- Venetoclax plus Azacitidine
- standard of care chemotherapy plus gemtuzumab ozogamicin
-
Essen, NRW, Germany
- +17 more
Jun 6, 2023
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and
Recruiting
- Acute Myeloid Leukemia
- +2 more
- Decitabine and Cedazuridine
- Venetoclax
-
Houston, TexasM D Anderson Cancer Center
Apr 1, 2022
Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +2 more
-
Suzhou, Jiangsu, ChinaQiu Huiying
Mar 28, 2023
Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in
Not yet recruiting
- Acute Myeloid Leukemia
- (no location specified)
Sep 22, 2023
Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax in combination with azacitidine and CAG
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Dec 20, 2022